EZH2, a histone 3 lysine 27 (H3K27) methyltransferase, is also significantly overexpressed in breast cancers, and elevated expression of EZH2 protein has been associated with poor prognoses for inflammatory basal-like breast cancers [13, 14]. Here, EZH2 is linked to breast carcinoma.